Research Article Open Access

Drug-Protein Interactions for Clinical Research by Nucleic Acid Programmable Protein Arrays-Quartz Crystal Microbalance with Dissipation Factor Monitoring Nanoconductometric Assay

Claudio Nicolini1, Rosanna Spera2, Nicola Luigi Bragazzi2 and Eugenia Pechkova2
  • 1 Arizona State University, United States
  • 2 University of Genoa, Italy

Abstract

Conductometric monitoring of drug-gene and drug-protein interactions is of fundamental importance in the field of molecular pharmacology. Here, we present our main findings and characterizations of an important antiblastic used in neuro-oncology (Temozolomide), interacting with selected proteins that represent predictive biomarkers of the rate survival of the patients, of the outcome of chemotherapy and resistance to drug itself (namely, BRIP1 and MLH1). We use our previously introduced two genes along with previously described Nucleic Acid Programmable Protein Arrays (NAPPA)-based nanoconductometric sensor. We performed a positive control (Temozolomide plus MLH1 protein), a negative control (Temozolomide plus BRIP1 protein) and a multi-gene experiment (Temozolomide plus BRIP1&MLH1 being co-expressed), showing that we are able to properly perform pharmacoproteomics tasks, discriminating each protein and drug unique conductance curve as well as their interactions, even in the presence of multi-proteins being immobilized. Moreover, in the last part of our paper, we used a multiple regression model in order to predict the behavior of Temozolomide when exposed to BRIP1&MLH1 co-expressed and we showed that we are able to predict the drug-protein interaction profile with a good regression coefficient.

American Journal of Biochemistry and Biotechnology
Volume 10 No. 3, 2014, 189-201

DOI: https://doi.org/10.3844/ajbbsp.2014.189.201

Submitted On: 16 October 2014 Published On: 17 November 2014

How to Cite: Nicolini, C., Spera, R., Bragazzi, N. L. & Pechkova, E. (2014). Drug-Protein Interactions for Clinical Research by Nucleic Acid Programmable Protein Arrays-Quartz Crystal Microbalance with Dissipation Factor Monitoring Nanoconductometric Assay. American Journal of Biochemistry and Biotechnology, 10(3), 189-201. https://doi.org/10.3844/ajbbsp.2014.189.201

  • 1,411 Views
  • 1,928 Downloads
  • 2 Citations

Download

Keywords

  • Conductometric Sensor
  • Nucleic Acid Programmable Protein Array (NAPPA)
  • Quartz Crystal Microbalance with Dissipation Factor Monitoring (QCM_D)
  • Cell Free Expression System
  • Temozolomide
  • Cancer
  • Pharmacoproteomics